title: PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation.
authors.affiliation: Department of Medicine A, University Hospital of Muenster, Muenster, Germany.
authors.forename: J C
authors.initials: JC
authors.lastname: Albring
authors.affiliation: Klinik für Hämatologie, Onkologie und Immunologie, Universitätsklinikum Gießen und Marburg, Standort Marburg, Philipps Universität Marburg, Baldingerstraße, Marburg, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Inselmann
authors.affiliation: Department of Medicine A, University Hospital of Muenster, Muenster, Germany.
authors.forename: T
authors.initials: T
authors.lastname: Sauer
authors.affiliation: Department of Medicine A, University Hospital of Muenster, Muenster, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Schliemann
authors.affiliation: Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Münster, Germany.
authors.forename: B
authors.initials: B
authors.lastname: Altvater
authors.affiliation: Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Münster, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Kailayangiri
authors.affiliation: Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Münster, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Rössig
authors.affiliation: Gerhard-Domagk-Institute of Pathology of the University Hospital, Münster, Germany.
authors.forename: W
authors.initials: W
authors.lastname: Hartmann
authors.affiliation: Klinik für Hämatologie, Onkologie und Immunologie, Universitätsklinikum Gießen und Marburg, Standort Marburg, Philipps Universität Marburg, Baldingerstraße, Marburg, Germany.
authors.forename: J R
authors.initials: JR
authors.lastname: Knorrenschild
authors.affiliation: Klinik für Hämatologie, Onkologie und Immunologie, Universitätsklinikum Gießen und Marburg, Standort Marburg, Philipps Universität Marburg, Baldingerstraße, Marburg, Germany.
authors.forename: K
authors.initials: K
authors.lastname: Sohlbach
authors.affiliation: Department of Medicine A, University Hospital of Muenster, Muenster, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Groth
authors.affiliation: Klinik für Hämatologie, Onkologie und Immunologie, Universitätsklinikum Gießen und Marburg, Standort Marburg, Philipps Universität Marburg, Baldingerstraße, Marburg, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Lohoff
authors.affiliation: Klinik für Hämatologie, Onkologie und Immunologie, Universitätsklinikum Gießen und Marburg, Standort Marburg, Philipps Universität Marburg, Baldingerstraße, Marburg, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Neubauer
authors.affiliation: Department of Medicine A, University Hospital of Muenster, Muenster, Germany.
authors.forename: W E
authors.initials: WE
authors.lastname: Berdel
authors.affiliation: Klinik für Hämatologie, Onkologie und Immunologie, Universitätsklinikum Gießen und Marburg, Standort Marburg, Philipps Universität Marburg, Baldingerstraße, Marburg, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Burchert
authors.affiliation: Department of Medicine A, University Hospital of Muenster, Muenster, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Stelljes
mesh_terms: D000328:Adult; D064591:Allografts; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D000077594:Nivolumab; D061026:Programmed Cell Death 1 Receptor / Q000037:antagonists & inhibitors* / Q000378:metabolism; D012008:Recurrence
chemical_list: D000911:Antibodies, Monoclonal; C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor; D000077594:Nivolumab